- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04631367
mHealth Intervention for Increasing COVID-19 Prevention Practices With Urban Refugee and Displaced Youth in Uganda
Kukaa Salama (Staying Safe): A Pre-Post Trial of a mHealth Social Group for Increasing COVID-19 Prevention Practices With Urban Refugee and Displaced Youth in Kampala, Uganda
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background & Objectives: The proposed study will be nested within an ongoing cluster-randomized HIV self-testing trial (Tushirikiane) in Kampala, Uganda. Using a pre-test/post-test design, the proposed study aims to evaluate the effectiveness of a RANAS-informed mHealth intervention on increasing self-efficacy of COVID-19 prevention practices with displaced/refugee youth aged 16-24 in Kampala, Uganda. This research will be conducted in 5 informal settlements ('slums') grouped into 3 clusters based on proximity (1: Kabalanga and Kasanga, 2: Katwe and Nsambya, 3: Rubaga) where most displaced/refugee persons in Kampala live.
Kukaa Salama Intervention: Participants will be invited to take part in a 8-week COVID-19 prevention program; this will involve receiving 1 SMS/week on COVID-19 prevention messaging, delivered using the WelTel secure platform. All SMS will be delivered in participants' language of choice including English, French, Swahili, Luganda, or Kinyarwanda. Participants will also be invited to take part in a weekly group discussion (15 persons/group) using a secure group conversation integration with WelTel. Each week the group discussions will discuss barriers and facilitators and brainstorm solutions to advance COVID-19 prevention. Participants can also ask the research assistant questions by SMS about COVID-19 during Monday-Friday business hours 9 am-5 pm and can also receive psychosocial support from a counselor from Interaid collaborating with the team and YARID. Regardless of participation in the survey or interview, all participants of the parent trial (Tushirikiane) will also be offered a parcel that contains a face mask, a bar of soap, and a small parcel of food from the partner agency YARID.
Participant Recruitment and Retention: Tushirikiane participants will be invited to take part in the COVID-19 supplement of voluntary questions related to COVID-19 (i.e., about knowledge and prevention) and subsequent Kukaa Salama intervention. The participants will be informed the COVID-19 survey and Kukaa Salama intervention is voluntary and will not affect their participation in the larger Tushirikiane study. Community collaborators will facilitate recruitment and retention; peer navigators will use multiple study reminder strategies (e.g. social media, texts) to maintain engagement, and we will utilize existing outreach and services by MARPI, YARID, and community partners.
Research Team Training: This research involves collaborations with the Ministry of Health's Most At Risk Population Initiative (MARPI) clinics and YARID's urban refugee youth empowerment centres in Kampala.
mHealth Training: This research involves a collaboration with WelTel's non-profit agency for the supportive SMS intervention. WelTel will develop an integration to include discussion groups in the SMS communication platform: SMS surveys, COVID-19 updates, and discussion content will be delivered via WelTel's secure platform. WelTel will support consolidated communication capture and streamlined data visualization to support ongoing analysis. Weekly COVID-19 informational SMS will inform the moderated discussion focus. Multiple 'chat' methods are planned, including: 'scenarios' mimicking real-life situations; a 'question box'; sharing COVID-19 mitigation photos; short movies/GIFs (6-8 seconds); 'memes'; songs; and motivational drivers. The peer navigators and research coordinator will review group discussions weekly to publish top responses to incentivize engagement. WelTel staff has already conducted training with the research team and peer navigators as part of the larger trial.
COVID-19 Prevention Practices: Participants will be surveyed at 3 time points (time 1: baseline; time 2: 8 weeks; time 3: 16 weeks). At baseline (time 1), participants will complete a RANAS-informed questionnaire adapted to COVID-19 (i.e., about knowledge and prevention practices). These COVID-19 related questions will be delivered by a research assistant who will enter the survey responses directly into a tablet (survey will be on the Survey CTO secure platform that runs online and offline). Following the 8-week Kukaa Salama intervention, participants will be asked to complete the same survey (time 2) and again at a 4-month follow up (time 3) to examine changes in COVID-19 knowledge, prevention, and impacts after the intervention and over time.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5S1V4
- Factor-Inwentash Faculty of Social Work, University of Toronto
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Enrolled within the Tushirikiane HIV-self Testing cluster randomized trial
- Live in one of the 5 slum/informal settlement sites (Kabalanga, Kasanga, Katwe, Nsambya Rubaga)
- Identify as a refugee/displaced person or have refugee parents
- Age 16-24 years
- Speak English, Luganda, French, Swahili, or Kinyarwanda
- Own or have access to a mobile phone for the duration of the study
Exclusion Criteria:
- Not currently enrolled in the Tushirikiane HIV-self Testing cluster randomized trial
- Lives outside of 5 selected study sites
- Does not identify as a refugee or does not have refugee parents
- Less than 16 or older than 24 years
- Does not speak English, Luganda, French, Swahili, or Kinyarwanda
- Does not have mobile phone
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Kukaa Salama: mHealth intervention
This is a pre-test/post-test trial, therefore all participants will receive the Kukaa Salama mHealth intervention and will be offered a COVID-19 prevention parcel.
|
Kukaa Salama is a 8-week social group program of COVID-19 prevention messaging, which includes sending informational SMS once per week and holding secure group discussions on COVID-19 prevention.
Weekly SMS messages will focus on COVID-19 knowledge, including information about transmission, hand washing, respiratory hygiene (coughing and sneezing in ways that won't spread germs), face masks, and physical distancing.
Participants can also respond to the SMS with any questions about COVID-19, and the study team will respond with further information and/or additional resources.
Weekly group chats will be administered using the customized WelTel platform, and will focus on discussions of how participants can apply and practice the information on COVID-19 prevention in their daily lives.
Each group chat will be composed of 15-20 participants, and will be facilitated by a research assistant in Kampala as well as a peer navigator.
Participants will be offered the opportunity to pick up a parcel that contains a face mask, bar of soap, and a small parcel of food from the partner agency YARID.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in COVID-19 Prevention Practices
Time Frame: Time 1 (1 week), Time 2 (8 week), Time 3 (month 16 week)
|
To assess changes in COVID-19 prevention practices, participants are asked to report on their self-efficacy (i.e.
ability, confidence, adherence) to practice hand and respiratory hygiene (i.e.
hand washing with soap, face mask usage) and physical distancing.
|
Time 1 (1 week), Time 2 (8 week), Time 3 (month 16 week)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in COVID-19 Risk Awareness
Time Frame: Time 1 (1 week), Time 2 (8 week), Time 3 (month 16 week)
|
To assess changes in COVID-19 risk awareness, participants are asked to report on their perceived risk and vulnerabilites to COVID-19 as well as as their knowledge of symptoms and severity.
|
Time 1 (1 week), Time 2 (8 week), Time 3 (month 16 week)
|
Changes in Attitude towards COVID-19
Time Frame: Time 1 (1 week), Time 2 (8 week), Time 3 (month 16 week)
|
To assess changes in attitudes towards COVID-19, participants are asked to report on their attitude (i.e.
feelings, costs/benefits) towards prevention practices as well as towards COVID-19 testing and potential vaccines.
|
Time 1 (1 week), Time 2 (8 week), Time 3 (month 16 week)
|
Changes in COVID-19 Norms
Time Frame: Time 1 (1 week), Time 2 (8 week), Time 3 (month 16 week)
|
To assess changes in COVID-19 norms, participants are asked to report on the percieved behaviours approved by others (i.e.
social pressues) towards COVID-19 prevention practices, transmission, and stigma.
|
Time 1 (1 week), Time 2 (8 week), Time 3 (month 16 week)
|
Changes in COVID-19 Self-Regulation
Time Frame: Time 1 (1 week), Time 2 (8 week), Time 3 (month 16 week)
|
To assess changes in COVID-19 self-regulation, participants are asked about their action plan for implementing COVID-19 prevention practices.
|
Time 1 (1 week), Time 2 (8 week), Time 3 (month 16 week)
|
Changes in Depression
Time Frame: Time 1 (1 week), Time 2 (8 week), Time 3 (month 16 week)
|
Depression outcomes will be assessed using the Patient Health Questionnaire -9 item (PHQ-9).
Higher scores mean a worse outcome.
Range 0-27.
|
Time 1 (1 week), Time 2 (8 week), Time 3 (month 16 week)
|
Sexual and Reproductive Health
Time Frame: Time 1 (1 week), Time 2 (8 week), Time 3 (month 16 week)
|
To assess changes in sexual and reproductive health, participants are asked to report on personal experiences (e.g.
intimate partner violence) as well as perceived changes in the community (e.g.
violence, access to sexual and reproductive health services).
|
Time 1 (1 week), Time 2 (8 week), Time 3 (month 16 week)
|
Food and Water insecurity
Time Frame: Time 1 (1 week), Time 2 (8 week), Time 3 (month 16 week)
|
To assess changes in food and water insecurity, participants are asked to report on frequency of insufficient food (i.e.
going to bed hungry) and inadequate clean water.
|
Time 1 (1 week), Time 2 (8 week), Time 3 (month 16 week)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Carmen H Logie, PhD, University of Toronto, Canada
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- idrc_covid
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitätsspital ZürichEnrolling by invitation
-
Alexandria UniversityCompleted
Clinical Trials on Kukaa Salama: mHealth intervention
-
University of ConnecticutNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
The Hong Kong Polytechnic UniversityThe University of Hong Kong; Kwong Wah Hospital; University of Glasgow; Tsan Yuk...RecruitingQuality of Life | Family Relations | Postnatal DepressionHong Kong
-
Children's National Research InstituteNot yet recruitingSexually Transmitted Diseases
-
Kaiser PermanenteCompletedSmoking | Smoking CessationUnited States
-
KU LeuvenJomo Kenyatta University of Agriculture and TechnologyCompleted
-
University of FloridaCompleted
-
University of OklahomaActive, not recruitingChild Abuse | Parenting | Child Development | Child NeglectUnited States
-
American University of Beirut Medical CenterInternational Development Research Centre, Canada; Ministry of Public Health... and other collaboratorsCompletedHypertension | Diabetes Mellitus
-
China Medical University HospitalMinistry of Science and Technology, Taiwan; China Medical University, TaiwanUnknownHealth Behavior | Intervention StudyTaiwan
-
Fundació Institut de Recerca de l'Hospital de la...Recruiting